Published in Blood Weekly, May 17th, 1999
Bruce Carter, Novo Nordisk and ZymoGenetics (Seattle, Washington) said, "Researchers at ZymoGenetics discovered and cloned the human gene for Factor VII, on which NovoSeven was eventually based, in 1983. ZymoGenetics continued research to show that Factor VII could be produced in recombinant form from this gene. The project was then transferred to Novo...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.